%D8%AA%D9%84%D9%8A%D9%81_%D8%B1%D8%A6%D9%88%D9%8A_%D9%85%D8%AC%D9%87%D9%88%D9%84_%D8%A7%D9%84%D8%B3%D8%A8%D8%A8%D0%98%D0%B4%D0%B8%D0%BE%D0%BF%D0%B0%D1%82%D0%B8%D1%87%D0%BD%D0%B0_%D0%B1%D0%B5%D0%BB%D0%BE%D0%B4%D1%80%D0%BE%D0%B1%D0%BD%D0%B0_%D1%84%D0%B8%D0%B1%D1%80%D0%BE%D0%B7%D0%B0Fibrosi_pulmonar_idiop%C3%A0ticaCategory:Idiopathic_pulmonary_fibrosisIdiopathische_Lungenfibrose%CE%99%CE%B4%CE%B9%CE%BF%CF%80%CE%B1%CE%B8%CE%AE%CF%82_%CF%80%CE%BD%CE%B5%CF%85%CE%BC%CE%BF%CE%BD%CE%B9%CE%BA%CE%AE_%CE%AF%CE%BD%CF%89%CF%83%CE%B7Idiopathic_pulmonary_fibrosisFibrosis_pulmonar_idiop%C3%A1tica%D9%81%DB%8C%D8%A8%D8%B1%D9%88%D8%B2_%D8%B1%DB%8C%D9%88%DB%8C_%D8%A7%DB%8C%D8%AF%DB%8C%D9%88%D9%BE%D8%A7%D8%AA%DB%8C%DA%A9Idiopaattinen_keuhkofibroosiFibrose_pulmonaire_idiopathiqueFibrosi_polmonare_idiopatica%E7%89%B9%E7%99%BA%E6%80%A7%E8%82%BA%E7%B7%9A%E7%B6%AD%E7%97%87%D0%98%D0%B4%D0%B8%D0%BE%D0%BF%D0%B0%D1%82%D1%81%D0%BA%D0%B0_%D0%BF%D1%83%D0%BB%D0%BC%D0%BE%D0%BD%D0%B0%D0%BB%D0%BD%D0%B0_%D1%84%D0%B8%D0%B1%D1%80%D0%BE%D0%B7%D0%B0_(%D0%98%D0%9F%D0%A4)Idiopathische_pulmonale_fibrose%E0%AC%87%E0%AC%A1%E0%AC%BF%E0%AC%93%E0%AC%AA%E0%AC%BE%E0%AC%A5%E0%AC%BF%E0%AC%95_%E0%AC%AA%E0%AC%B2%E0%AC%AE%E0%AD%8B%E0%AC%A8%E0%AC%BE%E0%AC%B0%E0%AC%BF_%E0%AC%AB%E0%AC%BE%E0%AC%87%E0%AC%AC%E0%AD%8D%E0%AC%B0%E0%AD%8B%E0%AC%B8%E0%AC%BF%E0%AC%B8Idiopatyczne_w%C5%82%C3%B3knienie_p%C5%82uc%D0%98%D0%B4%D0%B8%D0%BE%D0%BF%D0%B0%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B9_%D0%BB%D0%B5%D0%B3%D0%BE%D1%87%D0%BD%D1%8B%D0%B9_%D1%84%D0%B8%D0%B1%D1%80%D0%BE%D0%B7Idiopathic_pulmonary_fibrosisIdiopatisk_lungfibrosQ2290446%E7%89%B9%E5%8F%91%E6%80%A7%E8%82%BA%E7%BA%A4%E7%BB%B4%E5%8C%96
about
sameAs
Mahjoub SharifSafety, Tolerability, and Efficacy Study of Idiopathic Pulmonary FibrosisStudy to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy AdultsStudy of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment StudyRace, Ethnicity, and Diffuse Parenchymal Lung DiseaseGenomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF)IPF Drug Deposition StudyAutoantibody Reduction Therapy in Patients With Idiopathic Pulmonary FibrosisThe Occurence of Inflammation and Oxidative Stress in Lung DiseasesTo Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy VolunteersNutritional Assessment in Idiopathic Pulmonary FibrosisBPF Genetics of ILD StudySelf-monitoring of Spirometry & Symptoms Via patientMpower App in Idiopathic Pulmonary FibrosisInhaled NAC in Treatment of IPFTraditional Chinese Medicine(TCM) Syndrome Classification of Idiopathic Pulmonary Fibrosis(IPF) and MetabolomicsA Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical TreatmentEvolution of Lung 18FDG Uptake in Patients With Idiopathic Pulmonary Fibrosis and Receiving PirfenidoneAcute Effects of Oxygen Supplementation Among IPF PatientsFamilies-At-risk for Interstitial Lung Disease StudyInhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary FibrosisEZ-2053 in the Prophylaxis of Acute Pulmonary Allograft RejectionLung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular CharacterizationTargeted Intervention for Patient Centered Outcome in Patients With Idiopathic Pulmonary FibrosisGenetics of IPF - Screening Study for Family MembersStatus and Develepment Mental Quality of Life COPD/IPF Inpatients Before and After Pulmonary RehabilitationA Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPFPreliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis PatientsImpact of a Systematic Palliative Care on Quality of Life, in Advanced Idiopathic Pulmonary Fibrosis.Investigating Idiopathic Pulmonary Fibrosis in Greece (INDULGE IPF)Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) ImagingExercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis PatientsA MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis ExacerbationsClinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary FibrosisSafety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174)Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary Fibrosis
P1050
P1911
Lung Regeneration: Endogenous and Exogenous Stem Cell Mediated Therapeutic ApproachesPharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future PerspectivesIdiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanibPirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-AnalysisClinical trials of investigational agents for IPF: a review of a Cochrane reportPirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse eventsThe psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature reviewConnective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trialsOckham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancerRole of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosisIdiopathic pulmonary fibrosis--a systematic review on methodology for the collection of epidemiological dataDistinct Roles of Wnt/β-Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary FibrosisImpact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.Genetics and early detection in idiopathic pulmonary fibrosisThe MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian populationMode of action of nintedanib in the treatment of idiopathic pulmonary fibrosisHydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?The current position of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis.Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanibUsual interstitial pneumonia-pattern fibrosis in surgical lung biopsies. Clinical, radiological and histopathological clues to aetiologyPulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives.Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.Blood Biomarkers in Idiopathic Pulmonary Fibrosis.The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies.Recommendations for perioperative management of lung cancer patients with comorbidities.Trade-offs in aging lung diseases: a review on shared but opposite genetic risk variants in idiopathic pulmonary fibrosis, lung cancer and chronic obstructive pulmonary disease.VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease.Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review.Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experienceMacrophages: friend or foe in idiopathic pulmonary fibrosis?The Role of TGF-β Signaling in Lung Cancer Associated with Idiopathic Pulmonary FibrosisThe Role of Occupational and Environmental Exposures in the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Narrative Literature ReviewIdiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular TargetsAtrial Fibrillation After PFO Closure
P921
Q16939468-b037014d-4cd9-faa9-232b-2370e3cdf9d5Q61864929-F6A00847-5641-42A8-845E-7849F3A0F550Q61902767-40E30D36-44A8-46FA-A325-8362ECF34563Q61915020-6AD59A90-D599-43A4-9D71-F76C91AAF7CEQ61915273-0D63FECA-FB54-4B56-B5A4-F162FDB85582Q61920772-9927F8EE-C805-4DC9-ABE1-72CA2290E39AQ61932695-7912218B-30D6-465F-AA7C-DC1EBFB381FCQ61938659-CBD19679-D3B6-4FA7-A3E5-D10BB1271519Q61957150-D74695B5-DC03-4446-9198-703FBB9570FDQ61957299-709FD2A0-4E36-40B8-B8A6-8FE7D41F7326Q61965983-0A7770A0-2595-4257-BE72-D4BF34CAB171Q61975436-D08FE992-7738-4D7F-9C61-AF01CA8D71D3Q61978993-F58F80C9-5EA9-4A42-A3F1-595EBC027D32Q62025450-7AD23D30-D8E8-408A-B30B-AB07AF236691Q62031338-83C538A9-BB6E-48DF-8203-45CFB4FBC04EQ62034311-32E341E9-04A3-45D8-8EC3-61A445A0C39BQ62034568-48BCDEF1-D2EC-46F1-9F27-22E5D3270735Q62039914-B0485B9C-3FEA-46B8-9C1B-8E7E164A32FDQ62041889-D7F23F2F-FB51-4FC8-B6FD-ED45EC602F54Q62041950-058FF514-7384-4695-96DE-579735131854Q62054002-377ADF7C-7043-45D9-91AD-FAE0E3DB9CC4Q62054338-3B4F1BBE-E001-480C-8F4F-E5EA85C6BAADQ62062840-9E1D9FB7-C086-4435-8750-E4F8FED56F29Q62105338-2DBB313A-F7C9-4CFB-A04A-018CAC59AFC4Q62105805-3B336A66-3679-4E9C-9DF4-79732984CA78Q62809332-EB171BBB-B293-41C8-B4C5-9B99F845EFDFQ62811468-B54E725D-98E1-4E06-88BB-BC268CBC1B89Q62812412-CA9872FB-AC02-45CB-98FA-3533D5DF1EC9Q62812970-EB7387E3-94F8-4147-AA7A-790B01B110F7Q62813167-127D3BE9-AC3B-4175-959D-C75BAC84172BQ62814467-DFDD98E0-354F-4195-9BA6-913BA0635FC2Q63012910-77868421-6B82-4CBB-8797-F7C3AECACDFFQ63228813-8954F8C8-C249-4903-B8DF-F2EB52B17C56Q63229135-6A2D79CD-AC45-440F-8A58-EAACE2742687Q63317954-78A5F149-D981-4277-8EDA-654C138E587DQ63319366-F3AD67E2-9CDB-40F9-BA96-9FD17EA6998FQ63322101-9B3B93D1-035B-414E-9CC5-6E88171CE8AFQ63322801-FC1DE5B5-978C-4AE6-A539-91503B431A86Q63333643-69D5E1F3-8E62-4A89-B7B3-42E6687708FCQ63334875-906AC45F-8FDE-4CCB-AAC5-6D539895FFD8
P1050
description
Krankheit
@de
chronic, irreversible and ulti ...... ssive decline in lung function
@en
enfermedad crónica y mortal qu ...... gresiva de la función pulmonar
@es
malattia dell'apparato respiratorio
@it
مرض يصيب الإنسان
@ar
ସ୍ଥାୟୀ, ଅଣଲେଉଟା ଓ ଅବଶେଷରେ ଘାତକ ରୋଗ ଯେଉଁଥିରେ ଫୁସଫୁସ କାମ କମିଯାଏ ।
@or
name
Idiopaattinen keuhkofibroosi
@fi
Idiopatisk lungefibrose
@da
Idiopatyczne włóknienie płuc
@pl
ffibrosis ysgyfeiniol idiopathig
@cy
fibrose pulmonaire idiopathique
@fr
fibrosi polmonare idiopatica
@it
fibrosi pulmonar idiopàtica
@ca
fibrosis pulmonar idiopática
@es
fibroză pulmonară idiopatică
@ro
idiopathic pulmonary fibrosis
@en
type
label
Idiopaattinen keuhkofibroosi
@fi
Idiopatisk lungefibrose
@da
Idiopatyczne włóknienie płuc
@pl
ffibrosis ysgyfeiniol idiopathig
@cy
fibrose pulmonaire idiopathique
@fr
fibrosi polmonare idiopatica
@it
fibrosi pulmonar idiopàtica
@ca
fibrosis pulmonar idiopática
@es
fibroză pulmonară idiopatică
@ro
idiopathic pulmonary fibrosis
@en
altLabel
FIBROCYSTIC PULMONARY DYSPLASIA
@en
Fibrosis pulmonar idiopatica
@es
Fibrotisoiva alveoliitti
@fi
IDIOPATHIC PULMONARY FIBROSIS, FAMILIAL
@en
IPF
@da
IPF
@nl
IPF
@pl
Idiopatisk lungfibros
@sv
Włóknienie płuc
@pl
cryptogenic fibrosing alveolitis
@en
prefLabel
Idiopaattinen keuhkofibroosi
@fi
Idiopatisk lungefibrose
@da
Idiopatyczne włóknienie płuc
@pl
ffibrosis ysgyfeiniol idiopathig
@cy
fibrose pulmonaire idiopathique
@fr
fibrosi polmonare idiopatica
@it
fibrosi pulmonar idiopàtica
@ca
fibrosis pulmonar idiopática
@es
fibroză pulmonară idiopatică
@ro
idiopathic pulmonary fibrosis
@en
P486
P6366
P646
P1417
topic/idiopathic-pulmonary-fibrosis
P1461
idiopathic-pulmonary-fibrosis
P1692
P1995
P2892
P31
P373
Idiopathic pulmonary fibrosis
P3827
idiopathic-pulmonary-fibrosis